Why is Surgery Partners stock surging today?

Surgery Partners stock surged +21.2% in pre-open trading after reports surfaced Sunday evening that Bon Secours Mercy Health is nearing an agreement to acquire a controlling stake in the outpatient surgical care provider, with the deal valuing the company at approximately $6 billion including its roughly $3.5 billion debt load, and implying a per-share price of around $20.

The Financial Times first reported the late-stage nature of the negotiations, with sources indicating an announcement could come as early as today.

A key structural detail supporting investor confidence in the deal is that Bain Capital, which has held nearly a 40% stake in Surgery Partners since 2017, is expected to retain its position under the proposed transaction rather than exit.

This follows a prior failed attempt in 2025 in which Bain itself sought to take Surgery Partners private at an even higher enterprise valuation, underscoring the persistent strategic interest in the company’s network of over 176 surgical centers and hospitals spanning 30 U.S. states.

The broader market provided little directional influence, with the S&P 500 posting only a modest gain and the Nasdaq essentially flat, confirming that today’s sharp move in SGRY is entirely attributable to the M&A headline.

The deal also fits a well-established trend of hospital systems expanding into outpatient surgical facilities to diversify revenue away from traditional inpatient settings, adding strategic logic to the premium being offered.

Taken together, the combination of a credible acquirer, an attractive per-share premium relative to a stock that had declined roughly 31% over the prior year, and the prospect of a near-term announcement drove pre-market buyers to rapidly push SGRY shares toward the implied deal price, with the stock trading at $19.09 — still modestly below the reported $20 offer price, reflecting residual deal-completion risk.